Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment: A Nationwide Retrospective Study in Japan.
Okamura A, Watanabe M, Okui J, Matsuda S, Takemura R, Kawakubo H, Takeuchi H, Muto M, Kakeji Y, Kitagawa Y, Doki Y. Okamura A, et al. Among authors: doki y. Ann Surg Oncol. 2023 Apr;30(4):2176-2185. doi: 10.1245/s10434-022-12960-9. Epub 2022 Dec 17. Ann Surg Oncol. 2023. PMID: 36528742
Is Thoracic Duct Resection Necessary for Esophageal Squamous Cell Carcinoma Patients Treated with Neoadjuvant Chemoradiotherapy? A Propensity-Matched Analysis Based on the Comprehensive Registry of Esophageal Cancer in Japan.
Oshikiri T, Numasaki H, Oguma J, Toh Y, Watanabe M, Muto M, Kakeji Y, Doki Y. Oshikiri T, et al. Among authors: doki y. Ann Surg Oncol. 2023 May;30(5):2691-2698. doi: 10.1245/s10434-022-12891-5. Epub 2022 Dec 18. Ann Surg Oncol. 2023. PMID: 36529778
Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Matsuda S, Kitagawa Y, Okui J, Okamura A, Kawakubo H, Takemura R, Muto M, Kakeji Y, Takeuchi H, Watanabe M, Doki Y. Matsuda S, et al. Among authors: doki y. Ann Surg. 2023 Aug 1;278(2):e234-e239. doi: 10.1097/SLA.0000000000005701. Epub 2022 Oct 29. Ann Surg. 2023. PMID: 36538635
[No title available]
[No authors listed] [No authors listed] PMID: 36602666
[No title available]
[No authors listed] [No authors listed] PMID: 36611068
Surgical outcomes of reconstruction using the gastric tube and free jejunum for cervical esophageal cancer: analysis using the National Clinical Database of Japan.
Miyawaki Y, Tachimori H, Nakajima Y, Sato H, Fujiwara N, Kawada K, Miyata H, Sakuramoto S, Shimada H, Watanabe M, Kakeji Y, Doki Y, Kitagawa Y. Miyawaki Y, et al. Among authors: doki y. Esophagus. 2023 Jul;20(3):427-434. doi: 10.1007/s10388-023-00997-y. Epub 2023 Mar 10. Esophagus. 2023. PMID: 36899133
Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in Japan.
Okamura A, Watanabe M, Okui J, Matsuda S, Takemura R, Kawakubo H, Takeuchi H, Muto M, Kakeji Y, Kitagawa Y, Doki Y. Okamura A, et al. Among authors: doki y. Esophagus. 2023 Jul;20(3):465-473. doi: 10.1007/s10388-023-01002-2. Epub 2023 Apr 8. Esophagus. 2023. PMID: 37029845
1,636 results